Journal of International Oncology››2015,Vol. 42››Issue (7): 522-524.doi:10.3760/cma.j.issn.1673-422X.2015.07.012
Previous ArticlesNext Articles
Wang Linjun, Hua Dong
Online:
2015-07-08Published:
2015-05-26Contact:
Hua Dong E-mail:wx89211@163.comWang Linjun, Hua Dong. Roles of transient receptor potential canonical channels in tumors[J]. Journal of International Oncology, 2015, 42(7): 522-524.
[1] Nesin V, Tsiokas L. TRPC1[J]. Handb Exp Pharmacol, 2014, 222: 15-51. [2] Eder P, Molkentin JD. TRPC channels as effectors of cardiac hypertrophy[J]. Circ Res, 2011, 108(2): 265-272. [3] Rohacs T. Regulation of transient receptor potential channels by the phospholipase C pathway[J]. Adv Biol Regul, 2013, 53(3): 341-355. [4] El Hiani Y, Ahidouch A, OuadidAhidouch H, et al. Extracellular signalregulated kinases 1 and 2 and TRPC1 channels are required for calciumsensing receptorstimulated MCF7 breast cancer cell proliferation[J]. Cell Physiol Biochem, 2009, 23(46): 335-346. [5] Tajeddine N, Gailly P. TRPC1 protein channel is major regulator of epidermal growth factor receptor signaling[J]. J Biol Chem, 2012, 287(20): 16146-16157. [6] Bomben VC, Turner KL, Sontheimer H, et al. Transient receptor potential canonical channels are essential for chemotactic migration of human malignant gliomas[J]. J Cell Physiol, 2011, 226(7): 1879-1888. [7] Yang SL, Cao Q, Wang YZ, et al. Transient receptor potential channel C3 contributes to the progression of human ovarian cancer[J]. Oncogene, 2009, 28(10): 1320-1328. [8] Saito H, Minamiya Y, Ogawa J, et al. Expression of the transient receptor potential channel c3 correlates with a favorable prognosis in patients with adenocarcinoma of the lung[J]. Ann Surg Oncol, 2011, 18(12): 3377-3383. [9] Zhang Q, He J, Wang D, et al. Expression of transient receptor potential canonical channel proteins in human nonsmall cell lung cancer[J]. Zhongguo Fei Ai Za Zhi, 2010, 13(6): 612-616. [10] Jiang HN, Zeng B, Xu SZ, et al. Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human nonsmall cell lung cancer[J]. PLoS One, 2013, 8(6): e67637. [11] Zeng B, Yuan C, Xu SZ, et al. TRPC channels and their splice variants are essential for promoting human ovarian cancer cell proliferation and tumorigenesis[J]. Curr Cancer Drug Targets, 2013, 13(1): 103-116. [12] Jiang HN, Zeng B, Zhang Y, et al. Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human nonsmall cell lung cancer[J]. PLoS One, 2013, 8(6): e67637. [13] Ma X, Cai Y, Yao X, et al. Transient receptor potential channel TRPC5 is essential for Pglycoprotein induction in drugresistant cancer cells[J]. Proc Natl Acad Sci USA, 2012, 109(40): 16282-16287. [14] Ma X, Chen Z, Hua D, et al. Essential role for TrpC5containing extracellular vesicles in breast cancer with chemotherapeutic resistance[J]. Proc Natl Acad Sci USA, 2014, 111(17): 6389-6394. [15] Ding X, He Z, Wang Y, et al. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma[J]. J Natl Cancer Inst, 2010, 102(14): 1052-1068. [16] Ge R, Tai Y, Wang Y, et al. Critical role of TRPC6 channels in VEGFmediated angiogenesis[J]. Cancer Lett, 2009, 283(1): 43-51. [17] Cai R, Ding X, Wang Y, et al. Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells[J]. Int J Cancer, 2009, 125(10): 2281-2287. [18] Ding X, He Z, Wang Y, et al. Targeting TRPC6 channels in oesophageal carcinoma growth[J]. Expert Opin Ther Targets, 2010, 14(5): 513-527. [19] Yue D, Wang Y, Ren CS, et al. Expression of TRPC6 in benign and malignant human prostate tissues[J]. Asian J Androl, 2009, 11(5): 541-547. [20] Wang Y, Yue D, Li K, et al. The role of TRPC6 in HGFinduced cell proliferation of human prostate cancer DU145 and PC3 cells[J]. Asian J Androl, 2010, 12(6): 841-852. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[5] | Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353. |
[6] | Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[7] | Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[8] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[9] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[11] | Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||